Jenburkt Pharmaceuticals Ltd

NSE: JENBURPH · BSE: 524731 · Pharmaceuticals & Biotechnology · 16 announcements

Share price: ₹892.10
Market cap: ₹393.7 Cr
Revenue (annual): ₹168.7 Cr
Net profit (annual): ₹34.74 Cr
P/E (TTM): 12.0×Sector 47.4×
Promoter holding: 46.62%-0.02% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 2 Management Change 2 Financial Results 2 Annual General Meeting 2 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

29 Jul 2026 17:29 IST BSE

Board Meeting Date

Jenburkt Pharmaceuticals Board Meeting Date

Jenburkt Pharmaceuticals scheduled a board meeting for August 6, 2026, to consider the company's standalone unaudited financial results for the quarter ended June 30, 2026.

Read the filing ↗